These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16984172)

  • 1. Organic azide inhibitors of cysteine proteases.
    Le GT; Abbenante G; Madala PK; Hoang HN; Fairlie DP
    J Am Chem Soc; 2006 Sep; 128(38):12396-7. PubMed ID: 16984172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
    Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
    Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncovalent tripeptidyl benzyl- and cyclohexyl-amine inhibitors of the cysteine protease caspase-1.
    Löser R; Abbenante G; Madala PK; Halili M; Le GT; Fairlie DP
    J Med Chem; 2010 Mar; 53(6):2651-5. PubMed ID: 20170165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid-phase synthesis of azidomethylene inhibitors targeting cysteine proteases.
    Yang PY; Wu H; Lee MY; Xu A; Srinivasan R; Yao SQ
    Org Lett; 2008 May; 10(10):1881-4. PubMed ID: 18407644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformationally constrained 1,3-diamino ketones: a series of potent inhibitors of the cysteine protease cathepsin K.
    Marquis RW; Yamashita DS; Ru Y; LoCastro SM; Oh HJ; Erhard KF; DesJarlais RL; Head MS; Smith WW; Zhao B; Janson CA; Abdel-Meguid SS; Tomaszek TA; Levy MA; Veber DF
    J Med Chem; 1998 Sep; 41(19):3563-7. PubMed ID: 9733481
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of interleukin-1beta converting enzyme (ICE or caspase 1) by aspartyl acyloxyalkyl ketones and aspartyl amidooxyalkyl ketones.
    Galatsis P; Caprathe B; Downing D; Gilmore J; Harter W; Hays S; Kostlan C; Linn K; Lunney E; Para K; Thomas A; Warmus J; Allen H; Brady K; Talanian R; Walker N
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5089-94. PubMed ID: 20674352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cysteine proteases by peptides containing aziridine-2,3-dicarboxylic acid building blocks.
    Schirmeister T
    Biopolymers; 1999; 51(1):87-97. PubMed ID: 10380356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of cysteine proteases.
    Govardhan CP; Abeles RH
    Arch Biochem Biophys; 1996 Jun; 330(1):110-4. PubMed ID: 8651683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodioxocin-3-ones and N-acyl-3-amino-3-buten-2-ones: novel classes of cathepsin K cysteine protease inhibitors.
    Yamashita DS; Xie R; Lin H; Wang B; Shi SD; Quinn CJ; Hemling ME; Hissong C; Tomaszek TA; Veber DF
    J Pept Res; 2004 Mar; 63(3):265-9. PubMed ID: 15049838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant.
    Berggren K; Johansson B; Fex T; Kihlberg J; Björck L; Luthman K
    Bioorg Med Chem; 2009 May; 17(9):3463-70. PubMed ID: 19362485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidyl epoxides extended in the P' direction as cysteine protease inhibitors: effect on affinity and mechanism of inhibition.
    Perlman N; Hazan M; Shokhen M; Albeck A
    Bioorg Med Chem; 2008 Oct; 16(19):9032-9. PubMed ID: 18789705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: peptidomimetic replacement of the P2 alpha-amino acid by a alpha-hydroxy acid.
    Wang Y; Guan L; Jia S; Tseng B; Drewe J; Cai SX
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1379-83. PubMed ID: 15713391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Succinic acid amides as P2-P3 replacements for inhibitors of interleukin-1beta converting enzyme (ICE or caspase 1).
    Galatsis P; Caprathe B; Gilmore J; Thomas A; Linn K; Sheehan S; Harter W; Kostlan C; Lunney E; Stankovic C; Rubin J; Brady K; Allen H; Talanian R
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5184-90. PubMed ID: 20656488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theoretical studies of binding modes of two covalent inhibitors of cysteine proteases.
    Drabik P; Politowska E; Czaplewski C; Kasprzykowski F; Lankiewicz L; Ciarkowski J
    Acta Biochim Pol; 2000; 47(4):1061-6. PubMed ID: 11996096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory.
    Desai PV; Patny A; Gut J; Rosenthal PJ; Tekwani B; Srivastava A; Avery M
    J Med Chem; 2006 Mar; 49(5):1576-84. PubMed ID: 16509575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and evaluation of aza-peptide epoxides as selective and potent inhibitors of caspases-1, -3, -6, and -8.
    James KE; Asgian JL; Li ZZ; Ekici OD; Rubin JR; Mikolajczyk J; Salvesen GS; Powers JC
    J Med Chem; 2004 Mar; 47(6):1553-74. PubMed ID: 14998341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors.
    Barrett DG; Catalano JG; Deaton DN; Hassell AM; Long ST; Miller AB; Miller LR; Ray JA; Samano V; Shewchuk LM; Wells-Knecht KJ; Willard DH; Wright LL
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1735-9. PubMed ID: 16376075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonpeptidic, noncovalent inhibitors of the cysteine protease cathepsin S.
    Thurmond RL; Beavers MP; Cai H; Meduna SP; Gustin DJ; Sun S; Almond HJ; Karlsson L; Edwards JP
    J Med Chem; 2004 Sep; 47(20):4799-801. PubMed ID: 15369380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncovering false positives on a virtual screening search for cruzain inhibitors.
    Malvezzi A; de Rezende L; Izidoro MA; Cezari MH; Juliano L; do Amaral A
    Bioorg Med Chem Lett; 2008 Jan; 18(1):350-4. PubMed ID: 17981033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhenium inhibitors of cathepsin B (ReO(SYS)X (where Y = S, py; X = Cl, Br, SPhOMe-p)): Synthesis and mechanism of inhibition.
    Mosi R; Baird IR; Cox J; Anastassov V; Cameron B; Skerlj RT; Fricker SP
    J Med Chem; 2006 Aug; 49(17):5262-72. PubMed ID: 16913715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.